Medical Communications
UK regulators do not back Roche’s breast cancer drug
May 20, 2016 Medical Communications, Research and Development, Sales and Marketing NICE, Perjeta, Roche, breast cancer, recommendation
Chugai partners with Osaka University in £62 million immunology collaboration
May 20, 2016 Medical Communications, Research and Development Chugai, collaboration, immunology, osaka university
Celator receives FDA breakthrough therapy designation for leukaemia drug
May 20, 2016 Medical Communications, Research and Development FDA, Vyxeos, acute myeloid leukaemia, breakthrough therapy, celator
Urgent action needed on antimicrobial resistance, says government report
May 19, 2016 Manufacturing and Production, Medical Communications, Research and Development ABPI, Lord Jim O'Neill, NICE, antimicrobial resistance
Relmada Therapeutics appoints new chief financial officer
May 17, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing chief financial officer, relmada
US pass new laws to combat opioid epidemic
May 13, 2016 Medical Communications, Sales and Marketing US, epidemic, fight back, new laws, opioids, reverse
EU approves Idelvion for haemophilia B treatment
May 13, 2016 Medical Communications, Research and Development CSL, EU, Idelvion, approval, haemophilia B
Sanofi Files Hart-Scott-Rodino notification for Medivation acquisition
May 13, 2016 Medical Communications, Sales and Marketing M&A, MA, Medivation, Sanofi, deal
Sobi, Biogen’s haemophilia B therapy gets European approval
May 13, 2016 Medical Communications, Research and Development, Sales and Marketing Biogen, haemophilia B, orphan designation, regulation, sobi
Bayer terminates clinical trial for hypertension due to safety concerns
May 13, 2016 Medical Communications, Research and Development Bayer, clinical trial, deaths, pulmonary hypertension, riociguat, safety concerns
Takeda appoints new chief financial officer
May 12, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, cfo, james kehoe
BMS says Nice refuses backing for its immunotherapy Opdivo to treat lung cancer
May 12, 2016 Medical Communications, Research and Development, Sales and Marketing
FDA issues warning about rare, but serious, side effect in Lilly antipsychotic drug
May 12, 2016 Medical Communications, Sales and Marketing Eli Lilly, FDA, anti-psychotic, boxed warning, lilly, olanzapine, skin condition
Nice recommends two blood tests to rule out pre-eclampsia in pregnant women
May 11, 2016 Medical Communications, Sales and Marketing NICE, Roche, regulation
UK pharma would benefit by remaining in EU, says ABPI
May 9, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Andrew Witty, EU, brexit, letter, observer, pascal soriot, remain, stay
Latest content
MedPharm appoints Jason Mieding as chief operating officer
Coriolis Pharma appoints Teun van der Heide as CEO
The evidence bar impacting UK medical cannabis access
